SULFISOXAZOLE DIOLAMINE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for sulfisoxazole diolamine and what is the scope of freedom to operate?
Sulfisoxazole diolamine
is the generic ingredient in two branded drugs marketed by Roche and Sola Barnes Hind, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.Summary for SULFISOXAZOLE DIOLAMINE
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 2 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 13 |
| Patent Applications: | 757 |
| DailyMed Link: | SULFISOXAZOLE DIOLAMINE at DailyMed |
US Patents and Regulatory Information for SULFISOXAZOLE DIOLAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | GANTRISIN | sulfisoxazole diolamine | OINTMENT;OPHTHALMIC | 008414-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sola Barnes Hind | SULFISOXAZOLE DIOLAMINE | sulfisoxazole diolamine | SOLUTION/DROPS;OPHTHALMIC | 084148-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Roche | GANTRISIN | sulfisoxazole diolamine | INJECTABLE;INJECTION | 006917-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Roche | GANTRISIN | sulfisoxazole diolamine | SOLUTION/DROPS;OPHTHALMIC | 007757-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
